Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Doxorubicin
Related studies linked through entity extraction aliases.
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The CARDIOPROTECT Trial
- Status
- RECRUITING
- Phase
- PHASE2
Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
- Status
- RECRUITING
- Phase
- PHASE3
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Status
- RECRUITING
- Phase
- PHASE1
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Status
- RECRUITING
- Phase
- PHASE3
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Status
- RECRUITING
- Phase
- PHASE3